Literature DB >> 18825496

First step in characterization of cis-acting sequences involved in fowl adenovirus 1 (CELO) packaging and its effect on the development of a helper-dependent vector strategy.

Claire Barra1, Patrick Langlois.   

Abstract

Adenovirus-based vectors are widely developed for potential utilization as vectors in vaccine and gene therapy strategies. We focused on developing a helper-dependent adenoviral (HD-Ad) vector for the potential use of CELO, a member of the Aviadenovirus genus, in avian species vaccination. Our aim was to localize sequences which could play an essential role in CELO genome encapsidation and, when deleted, was unable to produce viruses to develop a helper CELO virus. A panel of 6 mutants with deletions between nt 80 and 350 of the CELO genome was constructed and characterized for its ability to produce viable virus. To develop a helper-dependent adenoviral vector derived from CELO, a helper virus was developed by inserting loxP sequences around the region containing the identified putative packaging sequences. A LMH (Leghorn Male Hepatocarcinoma) cell line expressing Cre recombinase was developed to allow the excision of this region. We demonstrated that the region from nt 200 to 250 was important and the region from nt 250 to 300 at the left end of the CELO genome was essential for virus encapsidation. We also showed that the loxP-flanked region was efficiently removed in a Cre expressing cell line to produce a candidate helper virus.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18825496     DOI: 10.1007/s11262-008-0281-6

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  48 in total

1.  Interaction of the adenovirus IVa2 protein with viral packaging sequences.

Authors:  W Zhang; M J Imperiale
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

2.  Efficient FLPe recombinase enables scalable production of helper-dependent adenoviral vectors with negligible helper-virus contamination.

Authors:  P Umaña; C A Gerdes; D Stone; J R Davis; D Ward; M G Castro; P R Lowenstein
Journal:  Nat Biotechnol       Date:  2001-06       Impact factor: 54.908

3.  pMECA: a cloning plasmid with 44 unique restriction sites that allows selection of recombinants based on colony size.

Authors:  J M Thomson; W A Parrott
Journal:  Biotechniques       Date:  1998-06       Impact factor: 1.993

4.  Porcine adenovirus-3 as a helper-dependent expression vector.

Authors:  P Seshidhar Reddy; Neeraja Idamakanti; Lorne A Babiuk; Majid Mehtali; Suresh K Tikoo
Journal:  J Gen Virol       Date:  1999-11       Impact factor: 3.891

5.  Encapsidation of viral DNA requires the adenovirus L1 52/55-kilodalton protein.

Authors:  K E Gustin; M J Imperiale
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

6.  Bipartite structure and functional independence of adenovirus type 5 packaging elements.

Authors:  S I Schmid; P Hearing
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

7.  Interaction of the adenovirus L1 52/55-kilodalton protein with the IVa2 gene product during infection.

Authors:  K E Gustin; P Lutz; M J Imperiale
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

8.  Replication-defective bovine adenovirus type 3 as an expression vector.

Authors:  P S Reddy; N Idamakanti; Y Chen; T Whale; L A Babiuk; M Mehtali; S K Tikoo
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

9.  Identification of cis-acting sequences required for selective packaging of bovine adenovirus type 3 DNA.

Authors:  Li Xing; Linong Zhang; Jill Van Kessel; Suresh Kumar Tikoo
Journal:  J Gen Virol       Date:  2003-11       Impact factor: 3.891

Review 10.  Development of nonhuman adenoviruses as vaccine vectors.

Authors:  Dinesh S Bangari; Suresh K Mittal
Journal:  Vaccine       Date:  2005-09-23       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.